Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02822378 · ClinicalTrials.gov registry record · NA
Dried Plums and Bone Health in Postmenopausal Women
A NA study of Postmenopausal Osteoporosis, sponsored by Penn State University.
- Active
- Registry status
- NA
- Development phase
- 322
- Enrollment target
- 1
- Study location
NCT02822378: Active NA study of Postmenopausal Osteoporosis, sponsored by Penn State University.
NCT02822378 is a NA study of Postmenopausal Osteoporosis that is active but no longer recruiting, run by Penn State University. The registered enrollment target is 322 participants, below the 498-participant average among 14 other Postmenopausal Osteoporosis trials with a reported enrollment target (35% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02822378, a NA study of Postmenopausal Osteoporosis, is active but no longer recruiting, sponsored by Penn State University.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 322 participants
- Enrollment target
- 1
- Study location
Study Summary
Postmenopausal women often seek non-pharmacologic interventions for the protection of bone health. Previous research in humans and rodents has indicated that dietary dried plum consumption may be beneficial for bone health, especially in postmenopausal women. However, it is unknown in what quantity dried plums need to be consumed to be of benefit and through what mechanisms dried plums act to impact bone health. Therefore, the purpose of this study is to evaluate the impact of 52 weeks of dried plums consumption in varying quantities on bone mineral density (BMD), bone geometry, and estimated bone strength in postmenopausal women. The investigators also seek to evaluate the mechanisms underlying the effects of dried plums as a dietary supplement by assessing polyphenols and the bioavailable conjugated metabolites in the urine of postmenopausal women taking different doses of dietary dried plums. The investigators aim to further investigate the mechanisms of dried plum action on bone by measuring markers of bone metabolism in response to dried plum consumption.
Primary Outcome
Percent change in areal BMD measured during screening, and weeks 24 and 52 of the 52 week dietary intervention at the lumbar spine, total hip, and femoral neck.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Calcium supplement
- DIETARY_SUPPLEMENT Vitamin D supplement
- DIETARY_SUPPLEMENT Dried Plum
Study Locations (1)
Pennsylvania
- Women's Health and Exercise Laboratories, The Pennsylvania State University - University Park
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 322 participants |
| Start Date | 2016-06-01 |
| Est. Completion | 2026-12-31 |
| Phase | NA |
What the registry record for NCT02822378 still lists
NCT02822378 is an interventional study that assigns participants to a tested intervention. The registered 322 participants enrollment target is mid-sized for trials with a published cap, below the 498-participant average among 14 other Postmenopausal Osteoporosis trials with a reported enrollment target (35% lower).
The record links to 1 condition, with Postmenopausal Osteoporosis appearing as the primary indexed condition, and to 3 interventions - of which Calcium supplement is the first listed.
NCT02822378 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT02822378 about?
NCT02822378 is a clinical study titled "Dried Plums and Bone Health in Postmenopausal Women". Postmenopausal women often seek non-pharmacologic interventions for the protection of bone health. Previous research in humans and rodents has indicated that dietary dried plum consumption may be beneficial for bone health, especially in postmenopausal women. However, it is unknown in what quantity ...
What is the current status of trial NCT02822378?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 322 participants. The study started on 2016-06-01. Estimated completion is 2026-12-31.
What conditions does trial NCT02822378 study?
This clinical trial studies the following conditions: Postmenopausal Osteoporosis.
What interventions are being tested in trial NCT02822378?
The interventions under investigation include: Calcium supplement (DIETARY_SUPPLEMENT), Vitamin D supplement (DIETARY_SUPPLEMENT), Dried Plum (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT02822378?
This trial is sponsored by Penn State University, which has 219 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02822378 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Postmenopausal Osteoporosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02822378's enrollment target sits among peer trials
322 9th of 14 higher than 6 of 14 other Postmenopausal Osteoporosis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Postmenopausal Osteoporosis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Trial Evaluating Efficacy of AGA2118 in PostMenopausal Women wIth Low Bone MasS (ARTEMIS)
ACTIVE NOT RECRUITING · Phase 2
-
Anabolic Therapy in Postmenopausal Osteoporosis
ACTIVE NOT RECRUITING · Phase 4
-
Efficacy & Safety of Abaloparatide-Solid Microstructured Transdermal System in Postmenopausal Women With Osteoporosis
COMPLETED · Phase 3
-
A Study of Ibandronate (Boniva) to Evaluate Satisfaction in Women With Post-Menopausal Osteoporosis or Osteopenia
COMPLETED · Phase 4
-
A Study of Monthly Risedronate for Osteoporosis
COMPLETED · Phase 3
-
Delayed Release (DR) Risedronate Compared to Immediate Release (IR) in Postmenopausal Women
COMPLETED · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04090359 · 322 participants · Phase 4
Dual Mobility Acetabular Cups in Revision TJA
- NCT04924075 · 322 participants · Phase 2
Belzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL), Pancreatic Neuroendocrine Tumor (pNET), Von Hippel-Lindau (VHL) Disease-Associated Tumors, Advanced Gastrointestinal Stromal Tumor (wt GIST), or Solid Tumors With HIF-2α Related Genetic Alterations (MK-6482-015)
- NCT03715933 · 321 participants · Phase 1
Phase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas
- NCT05922878 · 321 participants · Phase 2
Study of ALTO-300 in MDD
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI